Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
União Química is one of the largest and most prominent pharmaceutical companies in Brazil, with a history spanning over 85 years. The company operates across several business units, including Human Health (Prescription, OTC, and Hospital), Animal Health (Agener), and Outsourcing (CMO/CDMO services). It maintains a robust manufacturing infrastructure with multiple state-of-the-art facilities producing a wide range of products such as antibiotics, anti-inflammatories, and anesthetics. Recently, the company has significantly expanded its capabilities into biotechnology and vaccine production, notably through partnerships for COVID-19 vaccine manufacturing. União Química is recognized for its vertical integration and its role as a key supplier to both the public and private healthcare sectors in Latin America.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Quimica.